Strattera (Eli Lilly and Company)
Welcome to the PulseAid listing for the Strattera drug offered from Eli Lilly and Company. This Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | Atomoxetine hydrochloride |
| SUBSTANCE NAME: | ATOMOXETINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2002-11-26 |
| END MARKETING DATE: | 0000-00-00 |
Strattera HUMAN PRESCRIPTION DRUG Details:
| Item Description | Strattera from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2002-11-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-3227_324a23e9-1d68-42ba-8643-85cb35d45e5d |
| PRODUCT NDC: | 0002-3227 |
| APPLICATION NUMBER: | NDA021411 |
Other ATOMOXETINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
